Tubulis

Gilead Kite booth at AACR 2026

Biotech

ASCO: Tubulis touts ovarian cancer data that attracted Gilead

With the acquisition deal now closed, Tubulis is poised to become a German antibody-drug conjugate innovation hub for Gilead.

Darren Incorvaia May 30, 2026 9:36am

Fully set dinner table

After 3 acquisitions, Gilead shifts focus to expanded pipeline

Apr 8, 2026 4:00am

Glowing puzzle piece fitting into puzzle

Gilead pays $3.1B for Tubulis to bolster oncology ADC pipeline

Apr 7, 2026 8:30am

cash money

Biotech's top money raisers: 2025

Mar 2, 2026 6:30am

Paragliding near Tu Le valley with landscape with green and yellow rice fields and blue cloudy sky North- Vietnam

Former Roche oncology head turns to Tubulis—Chutes & Ladders

Jan 9, 2026 8:30am

Cancer mutation precision medicine oncology targeted

ESMO: Tubulis' next-gen ADC lives up to hype with 59% ORR

Oct 19, 2025 4:15am